Combined Non-Invasive Cardiac Imaging and Genetic Testing of Elite Volleyball Players: A Ten-Year Experience.
Combined Non-Invasive Cardiac Imaging and Genetic Testing of Elite Volleyball Players: A Ten-Year Experience.
复制标题
DOI：
10.26502/fccm.92920220
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Grossfeld P
中科院分区：
文献类型：
--
作者：
Grossfeld P
运动员心源性猝死是毁灭性的事件。尽管在确定年轻运动员心源性猝死的潜在病理生理学和遗传基础方面已经取得了重大进展，但对于识别高危个体的成本效益筛查措施仍存在争议。在本报告中，我们描述了我们对美国男子和女子国家排球队的 150 名成员进行心血管评估的十年经验。通过结合病史、体检、超声心动图和基因检测，我们确定了一名先前未确诊的马凡综合征运动员，以及其他四名可能患有主动脉病的运动员。总而言之，这种方法是一种具有成本效益的策略，用于识别高危高运动员，从而可能采取挽救生命的干预措施，并提出了对所有高个子个体进行筛查的可行性问题。
Sudden cardiac death in athletes is a devastating event. Although significant progress has been made in identifying the underlying pathophysiology and genetic basis for sudden cardiac death in young athletes, controversy exists regarding cost-effective screening measures to identify at-risk individuals. In this report we describe our ten-year experience performing cardiovascular assessments on 150 members of the United States Men’s and Women’s National Volleyball teams. Through a combination of history, physical, echocardiography and genetic testing, we have identified one previously undiagnosed athlete with Marfan syndrome, along with four others with a possible aortopathy. Taken together, this approach is a cost-effective strategy for the identification of at-risk tall athletes leading to potentially lifesaving interventions, and raises the issue of the feasibility of screening for all tall individuals.